Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» evolocumab
evolocumab
New Detailed Phase 3 Data Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Patients With A Rare And Serious Genetic Disorder That Causes High Cholesterol
Yahoo/PR NewsWire
Sun, 06/1/14 - 11:57 am
cholesterol
hypercholesterolemia
evolocumab
Amgen
Amgen announces publication of data from Phase 3 LAPLACE-2 study of evolocumab
The Fly on the Wall
Tue, 05/13/14 - 10:21 pm
Amgen
evolocumab
Earnings Preview: Amgen's timeline for Evolocumab will be in focus
The Fly on the Wall
Tue, 04/22/14 - 03:33 pm
earnings
Amgen
evolocumab
Amgen Drug Cuts Cholesterol Levels In Pivotal Studies
TheStreet.com
Mon, 03/31/14 - 10:18 am
Amgen
cholesterol
evolocumab
Amgen Drug Slashes Bad Cholesterol Within Weeks of Treatment
Bloomberg
Sun, 03/30/14 - 10:35 am
Amgen
cholesterol
evolocumab
Amgen drug meets goal for those with high genetic cholesterol
Yahoo/Reuters
Mon, 03/17/14 - 10:25 am
Amgen
cholesterol
evolocumab
Amgen Inc's Deep Pipeline Offsets Some of the Price Risk
Motley Fool
Wed, 02/12/14 - 10:07 am
Amgen
earnings
evolocumab
Amgen Goes 6 for 6 Fighting Cholesterol
Motley Fool
Sat, 02/1/14 - 10:52 am
Amgen
cholesterol
hypercholesterolemia
evolocumab
Amgen's cholesterol fighter succeeds in 5th late-stage study
Yahoo/Reuters
Fri, 01/31/14 - 08:09 am
Amgen clinical trials
evolocumab
familial hypercholesterolemia
Amgen extends PhIII sweep with more promising results for PCSK9 drug
Fierce Biotech
Wed, 01/29/14 - 10:27 am
Amgen
PCSK9 inhibitors
evolocumab
Amgen cholesterol drug meets goal of third late stage trial
Yahoo/Reuters
Thu, 01/23/14 - 05:53 pm
Amgen
evolocumab
PCSK9 inhibitors
Amgen cholesterol drug succeeds in late-stage trial
Yahoo/Reuters
Thu, 12/19/13 - 11:13 am
Amgen
cholesterol
evolocumab
PCSK9 inhibitors
Amgen announces MENDEL-2 Phase 3 trial met co-primary endpoints
Yahoo/Fly on the Wall
Tue, 12/17/13 - 09:37 am
Amgen
evolocumab
cholesterol
Slouching Toward Phase 3: Progress Report On New Cholesterol Drugs At The AHA
Forbes
Mon, 11/25/13 - 09:12 am
cholesterol
PCSK9 inhibitors
evolocumab
Amgen
Data on Amgen's Pipeline Candidates
Yahoo/Zacks.com
Thu, 11/21/13 - 11:05 am
Amgen
evolocumab
PCSK9 inhibitors
cholesterol
Talimogene Laherparepvec
Pages
« first
‹ previous
1
2